TrialJournal of Alzheimer's disease : JAD2017

A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Oral ELND005 (scyllo-Inositol) in Young Adults with Down Syndrome without Dementia.

Michael S Rafii et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.